Lymphohistiocytosis, Hemophagocytic
Showing 26 - 50 of 131
Hemophagocytic Lymphohistiocytoses, Cytokine Storm Trial in Hangzhou (Dexamethasone, Etoposide, Ruxolitinib)
Not yet recruiting
- Hemophagocytic Lymphohistiocytoses
- Cytokine Storm
- Dexamethasone
- +2 more
-
Hangzhou, Zhejiang, ChinaThe Children's Hospital of Zhejiang University School of Medicin
Aug 4, 2022
Acute Lymphoblastic Leukemia, Myelodysplastic Syndrome, Acute Myeloid Leukemia Trial in Houston (iCaspase9-transduced T cells,
Active, not recruiting
- Acute Lymphoblastic Leukemia
- +9 more
- iCaspase9-transduced T cells
- AP1903
-
Houston, Texas
- +1 more
Jul 22, 2022
Chidamide, Hemophagocytic Lymphohistiocytosis Trial in Beijing (Chidamide combines with VP-16 and methylprednisolone)
Recruiting
- Chidamide
- Hemophagocytic Lymphohistiocytosis
- Chidamide combines with VP-16 and methylprednisolone
-
Beijing, Beijing, ChinaBeijing Friendship Hospital
Nov 29, 2021
Early Detection of Epstein-Barr Virus Related Disease.
Active, not recruiting
- Post-transplant Lymphoproliferative Disorder
- +8 more
-
Aarhus, Central Region Of Denmark, DenmarkAarhus University Hospital
Dec 12, 2022
Adult Hemophagocytic Lymphohistiocytosis in Critically Ill
Recruiting
- Hemophagocytic Lymphohistiocytosis
-
Berlin, GermanyDepartment of Anesthesiology and Operative Intensive Care Medici
Jul 13, 2021
Granulomatosis With Polyangiitis, Hemophagocytic Syndrome Trial in Changchun (Meperizumab injection, NUCALA®)
Not yet recruiting
- Granulomatosis With Polyangiitis
- Hemophagocytic Syndrome
- Meperizumab injection
- NUCALA®
-
Changchun, Jilin, ChinaAffiliated Hospital of Changchun University of Traditional Chine
Apr 28, 2022
Children and Adult Hemophagocytic Syndrome (HLHa)
Completed
- Hemophagocytic Syndrome
- Identification of biological markers
-
Paris, FranceClinical Research Unit
Nov 19, 2021
Hemophagocytic Lymphohistiocytosis (HLH) Trial in Paris (Alemtuzumab, Methyl Prednisolone (MP), Cyclosporin A (CSA))
Completed
- Hemophagocytic Lymphohistiocytosis (HLH)
- Alemtuzumab
- +2 more
-
Paris, FranceHôpital Necker-Enfants Malades
Apr 13, 2021
Immune Deficiency Disorders, Severe Combined Immunodeficiency, Chronic Granulomatous Disease Trial in Saint Louis (Transplant
Recruiting
- Immune Deficiency Disorders
- +13 more
- Transplant preparative regimen of alemtuzumab, fludarabine, thiotepa, and melphalan
-
Saint Louis, MissouriWashington University
Apr 25, 2022
Macrophage Activation Syndrome, Lymphohistiocytosis, Hemophagocytic, Arthritis, Juvenile Trial in Worldwide (Emapalumab)
Completed
- Macrophage Activation Syndrome
- +3 more
-
Cincinnati, Ohio
- +4 more
May 16, 2022
Acute Lymphoblastic Leukemia in Remission, Acute Myeloid Leukemia in Remission, MDS Trial in Houston (CliniMACS)
Not yet recruiting
- Acute Lymphoblastic Leukemia in Remission
- +10 more
- CliniMACS
-
Houston, Texas
- +1 more
Dec 8, 2022
HLH Trial in Beijing (Zanubrutinib)
Recruiting
- HLH
-
Beijing, ChinaBeijing Friendship Hospital, Capital Medical University
Apr 2, 2022
Hemophagocytic Syndrome, T/NK-Cell Lymphoma Trial in Zhengzhou (Ruxolitinib, Etoposide, Dexamethasone, Gemcitabine,
Recruiting
- Hemophagocytic Syndrome
- T/NK-Cell Lymphoma
- Ruxolitinib, Etoposide, Dexamethasone, Gemcitabine, Pegaspargase, cis-platinum
-
Zhengzhou, Henan, ChinaOncology Department of The First Affiliated Hospital of Zhengzho
Aug 3, 2021
Hemophagocytic Lymphohistiocytosis, Chronic Active Epstein-Barr Virus Infection, Chronic Granulomatous Disease Trial in Canada,
Completed
- Hemophagocytic Lymphohistiocytosis
- +5 more
- Hematopoietic Stem Cell Transplant
-
Birmingham, Alabama
- +21 more
Dec 6, 2022
Hemophagocytic Syndrome (HPS) Trial in Ann Arbor (Ruxolitinib)
Completed
- Hemophagocytic Syndrome (HPS)
-
Ann Arbor, MichiganUniversity of Michigan Comprehensive Cancer Center
Jan 4, 2021
Primary Hemophagocytic Lymphohistiocytosis Trial in Worldwide (Emapalumab)
Active, not recruiting
- Primary Hemophagocytic Lymphohistiocytosis
-
Phoenix, Arizona
- +27 more
Nov 4, 2021
Epstein-Barr Virus (EBV)-Associated Diseases, EBV+ Lymphoproliferative Disease With Primary Immunodeficiency (PID LPD), EBV+
Recruiting
- Epstein-Barr Virus (EBV)-Associated Diseases
- +13 more
- Tabelecleucel
-
Los Angeles, California
- +39 more
Nov 9, 2022
Prognosis and Therapeutic Decision Tool for Autoimmunity and
Not yet recruiting
- Autoimmune Lymphoproliferative Syndrome
- +19 more
- Collection of samples
- (no location specified)
May 26, 2021
Macrophage Activation Syndrome, Secondary Hemophagocytic Lymphohistiocytosis, Still Disease Trial in Worldwide (Emapalumab)
Recruiting
- Macrophage Activation Syndrome
- +6 more
-
Birmingham, Alabama
- +41 more
Jan 3, 2023
Hemophagocytic Lymphohistiocytosis Trial in Canada, United States (ATG, rabbit, Etoposide, Methotrexate)
Completed
- Hemophagocytic Lymphohistiocytosis
- ATG, rabbit
- +4 more
-
Phoenix, Arizona
- +14 more
Sep 21, 2020
Bone Marrow Failure Syndrome, Thalassemia, Sickle Cell Disease Trial in Gainesville (Thiotepa--single daily dose,
Recruiting
- Bone Marrow Failure Syndrome
- +15 more
- Thiotepa--single daily dose
- Thiotepa--escalated dose
-
Gainesville, FloridaUF Health Shands Children's Hospital
Jul 8, 2021
Hemophagocytic Syndrome Trial in Beijing (PEG-rhG-CSF, rhG-CSF)
Not yet recruiting
- Hemophagocytic Syndrome
-
Beijing, ChinaBeijing Friendship Hospital
Aug 3, 2020
EBV Infection Trial in Beijing (PD1 antibody, lenalidomide)
Recruiting
- EBV Infection
- PD1 antibody
- lenalidomide
-
Beijing, Beijing, ChinaBeijing Friendship Hospital, Capital Medical University
Jan 4, 2022
PD-1 Antibody, Mixed Chimerism Trial in Beijing (Toripalimab Injection)
Not yet recruiting
- PD-1 Antibody
- Mixed Chimerism
- Toripalimab Injection
-
Beijing, Beijing, ChinaBeijing Friendship Hospital, Capital Medical University
Jun 27, 2021
Interferon Gamma and Other Inflammatory Mediators in
Completed
- Hemophagocytic Lymphohistiocytosis
- Blood Draws
- Data Collection
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Mar 16, 2020